Ziel
This research addresses a clinical problem with an innovative approach. Pancreatic cancer is one of the deadliest cancers and only 10% of patients survive 5 years after diagnosis. To find better therapies, we need patient-specific models that mimic the biology of tumour tissues and target interactions between different cell types. We will develop a controllable platform for modelling the human disease in the laboratory. We will use our new platform to discover better ways of treating the disease.
Wissenschaftliches Gebiet
Schlüsselbegriffe
Programm/Programme
- HORIZON.1.1 - European Research Council (ERC) Main Programme
Thema/Themen
Finanzierungsplan
HORIZON-ERC-POC - HORIZON ERC Proof of Concept GrantsGastgebende Einrichtung
LEIBNIZ-INSTITUT FUR POLYMERFORSCHUNG DRESDEN EV
Netto-EU-Beitrag
€ 150 000,00
Adresse
HOHE STRASSE 6
01069 Dresden
Deutschland
01069 Dresden
Deutschland
Region
Sachsen
Dresden
Dresden, Kreisfreie Stadt
Aktivitätstyp
Research Organisations
Links
Gesamtkosten
Keine Daten